Will Spooren, Ph.D.

Section Head, Behavioural Pharmacology and Preclinical Imaging, F. Hoffmann-La Roche

SFARI Investigator Website

Will Spooren is section head of behavioral pharmacology and preclinical imaging at Hoffman-La Roche. His group is responsible for providing in vivo characterization of drug candidates through the course of drug discovery an`d development process. He co-led the European Autism Interventions – A Multicentre Study for Developing New Medications (EU-AIMS) with Declan Murphy and currently serves as the industry project lead in the Autism Innovative Medicine Studies-2-Trials (AIMS-2-Trials).

Read More

Funded Projects

SFARI Funded Publications

Subscribe to our newsletter and receive SFARI funding announcements and news